Pfizer Inc annual earnings per share (EPS) for fiscal TTM was $1.31, a decrease of 4.4% from $1.37 in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| EPS (annual) | TTM → 2026-03-31 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (EPS) | $1.31 | $1.37 | $1.41 | $0.37 | $5.47 | $3.88 | $1.63 | $2.87 | $1.87 | $17.58 | $5.86 | $5.57 | $7.07 | $1.69 | $1.30 | $1.11 | $1.02 | $1.23 | $1.19 | $1.18 | $1.52 |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| EPS (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (EPS) | $0.47 | $-0.29 | $0.62 | $0.51 | $0.52 | $0.07 | $0.78 | $0.00 |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More PFE metrics: Revenue · Gross Profit · Operating Income · Net Income · EBITDA · Free Cash Flow · Shares Outstanding
All PFE financial statements → Interactive PFE charts →
About TickerBase · Data methodology & sources